Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions? - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Gut Year : 2016

Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?

Abstract

No abstract available
Embargoed file
Embargoed file
Visibility date is undetermined

Dates and versions

inserm-02532895 , version 1 (28-04-2022)

Identifiers

Cite

André Lechel, Angélique Gougelet. Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?. Gut, 2016, 65 (7), pp.1073-1074. ⟨10.1136/gutjnl-2016-311446⟩. ⟨inserm-02532895⟩
84 View
2 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More